Status:
UNKNOWN
Anxiety And Depression During COVID-19 IN INDIA
Lead Sponsor:
Max Healthcare Insititute Limited
Conditions:
COVID-19
Eligibility:
All Genders
18-90 years
Brief Summary
1. To understand the prevalence of symptoms of Depression and Anxiety in general population during COVID-19 in India 2. To understand correlation between COVID-19 related factors and mental health sym...
Detailed Description
Aim: 1. To understand the prevalence of symptoms of Depression and Anxiety in general population during COVID-19 in India 2. To understand correlation between COVID-19 related factors and mental heal...
Eligibility Criteria
Inclusion
- Participants of the age of 18 years and above
- Participants residing in India
- Participants with minimum 10 years of education with basic knowledge of English
Exclusion
- Participants under the age of 18 years
- Participants residing outside of India
- Participants with previous history of any major psychiatric illness, psychiatric hospitalization or currently on any psychiatric medication.
Key Trial Info
Start Date :
April 24 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 24 2021
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04369300
Start Date
April 24 2020
End Date
February 24 2021
Last Update
July 15 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Max Super Speciality hospital
New Delhi, National Capital Territory of Delhi, India, 110017